The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Casarett and Doull's Toxicology: The Basic Science of Poisons
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_2 · Cited by 3,302
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., et al. (1997) · Science · doi:10.1126/science.277.5327.818 · Cited by 1,664
Strasser, A., O'Connor, L., & Dixit, V. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.217 · Cited by 1,351
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Cisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
Life-or-death decisions by the Bcl-2 protein family
Adams, J. M., & Cory, S. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01740-0 · Cited by 886
TRAIL and apoptosis induction by TNF-family death receptors
Wang, S., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207232 · Cited by 871
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15606 · Cited by 866
Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis
Daugas, E., Susin, S. A., Zamzami, N., Ferri, K. F., Irinopoulou, T., Larochette, N., Prévost, M., Leber, B., Andrews, D., Penninger, J., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.729 · Cited by 776
Norbury, C. J., & Zhivotovsky, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207532 · Cited by 701
High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresis
Hayes, D. M., Cvitkovic, E., Golbey, R. B., Scheiner, E., Helson, L., & Krakoff, I. H. (1977) · Cancer · doi:10.1002/1097-0142(197704)39:4<1372::aid-cncr2820390404>3.0.co;2-j · Cited by 626
Cisplatin: From DNA damage to cancer chemotherapy
Cohen, S. M., & Lippard, S. J. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)67026-0 · Cited by 615
Goossens, V, Grooten, J., De Vos, K., & Fiers, W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8115 · Cited by 596
Is Cisplatin-Induced Cell Death Always Produced by Apoptosis?
Gonzalez, V. M., Fuertes, M. A., Alonso, C., & Perez, J. M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09232-0 · Cited by 578
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin
Laughton, M. J., Halliwell, B., Evans, P. J., Robin, J., & Hoult, S. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90442-5 · Cited by 558
Charles F. Kettring prize. Fundamental studies with cisplatin
Rosenberg, B. (1985) · Cancer · doi:10.1002/1097-0142(19850515)55:10<2303::aid-cncr2820551002>3.0.co;2-l · Cited by 517
Oxidative Stress, Toxicology, and Pharmacology of CYP2E1
Caro, A. A., & Cederbaum, A. I. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121704 · Cited by 512
Cisplatin nephrotoxicity: molecular mechanisms.
Hanigan, M. H., & Devarajan, P. (2003) · PubMed · Cited by 476
Apoptosis‐inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis
Daugas, E., Nochy, D., Ravagnan, L., Loeffler, M., Susin, S. A., Zamzami, N., & Kroemer, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01731-2 · Cited by 466
Kemp, G., Rose, P., Lurain, J., Berman, M., Manetta, A., Roullet, B., Homesley, H., Belpomme, D., & Glick, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2101 · Cited by 463
Lieberthal, W., Triaca, V., & Levine, J. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.4.f700 · Cited by 449
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Faubel, S., Lewis, E. C., Reznikov, L., Ljubanovic, D., Hoke, T. S., Somerset, H., Oh, D.-J., Lu, L., Klein, C. L., Dinarello, C. A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119792 · Cited by 399
Barnes, P. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00159-8 · Cited by 395
Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria
Petrosillo, G., Ruggiero, F. M., & Paradies, G. (2003) · The FASEB Journal · doi:10.1096/fj.03-0012com · Cited by 384
[30] γ-Glutamyl transpeptidase
Meister, A., Tate, S. S., & Griffith, O. W. (1981) · Methods in Enzymology · doi:10.1016/s0076-6879(81)77032-0 · Cited by 377
Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells
Lieberthal, W., Menza, S. A., & Levine, J. S. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.2.f315 · Cited by 377
Anticancer Drug???Induced Kidney Disorders: Incidence, Prevention and Management
Kintzel, P. E. (2001) · Drug Safety · doi:10.2165/00002018-200124010-00003 · Cited by 355
Tumour necrosis factor α: a potential target for the therapy of solid tumours
Szlosarek, P. W., & Balkwill, F. R. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01196-3 · Cited by 355
Ali, B. H., & Al Moundhri, M. S. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.01.013 · Cited by 328
Santos, N. A. G., Catão, C. S., Martins, N. M., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2007) · Archives of Toxicology · doi:10.1007/s00204-006-0173-2 · Cited by 327
Self-citationKruidering, M., Van De Water, B., De Heer, E., Mulder, G. J., & Nagelkerke, J. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36493-6 · Cited by 325
Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells
Townsend, D. M., Deng, M., Zhang, L., Lapus, M. G., & Hanigan, M. H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000042803.28024.92 · Cited by 317
Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats
Atessahin, A., Yilmaz, S., Karahan, I., Ceribasi, A. O., & Karaoglu, A. (2005) · Toxicology · doi:10.1016/j.tox.2005.04.016 · Cited by 308
Kuhlmann, M., Burkhardt, G., & Kohler, H. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.12.2478 · Cited by 290
Pabla, N., Murphy, R. F., Liu, K., & Dong, Z. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90545.2008 · Cited by 283
Launay‐Vacher, V., Rey, J., Bagnis, C. I., Deray, G., & Daouphars, M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0711-0 · Cited by 282
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure
Ramesh, G., & Reeves, W. B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2003 · Cited by 282
Nick, J. A., Avdi, N. J., Young, S. K., Lehman, L. A., McDonald, P. P., Frasch, S. C., Billstrom, M. A., Henson, P. M., Johnson, G. L., & Worthen, G. S. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5257 · Cited by 281
Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways
Park, M. S., De Leon, M., & Devarajan, P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134858 · Cited by 279
Nephrotoxicity and Hydration Management for Cisplatin, Carboplatin, and Ormaplatin
Cornelison, T. L., & Reed, E. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1184 · Cited by 270
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice
Ramesh, G., & Reeves, W. B. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00401.2004 · Cited by 267
Yang, Z., Schumaker, L. M., Egorin, M. J., Zuhowski, E. G., Guo, Z., & Cullen, K. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1037 · Cited by 267
Kaushal, G. P., Kaushal, V., Hong, X., & Shah, S. V. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00026.x · Cited by 266
Old, L. J. (1988) · Scientific American · doi:10.1038/scientificamerican0588-59 · Cited by 261
SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE
Sastry, J., & Kellie, S. J. (2005) · Pediatric Hematology and Oncology · doi:10.1080/08880010590964381 · Cited by 258
Role of apoptosis in the pathogenesis of acute renal failure
Bonegio, R., & Lieberthal, W. (2002) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200205000-00006 · Cited by 251
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
Sánchez-González, P. D., López-Hernández, F. J., López-Novoa, J. M., & Morales, A. I. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.602662 · Cited by 250
Burns, T. F., & El‐Deiry, W. S. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199911)181:2<231::aid-jcp5>3.0.co;2-l · Cited by 241
Tsuruya, K., Ninomiya, T., Tokumoto, M., Hirakawa, M., Masutani, K., Taniguchi, M., Fukuda, K., Kanai, H., Kishihara, K., Hirakata, H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00709.x · Cited by 241
The nephrotoxicity of cisplatin
Goldstein, R. S., & Mayor, G. H. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90299-0 · Cited by 237
Beyaert, R., & Fiers, W. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80163-0 · Cited by 235
Sergedien≐, E., Jönsson, K., Szymusiak, H., Tyrakowska, B., Rietjens, I. M. C. M., & Č≐nas, N. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01561-6 · Cited by 234
Activation and involvement of p53 in cisplatin-induced nephrotoxicity
Wei, Q., Dong, G., Yang, T., Megyesi, J., Price, P. M., & Dong, Z. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00230.2007 · Cited by 232
The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1154 · Cited by 232
Naringenin attenuates cisplatin nephrotoxicity in rats
Badary, O. A., Abdel-Maksoud, S., Ahmed, W. A., & Owieda, G. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.11.005 · Cited by 230
Drug transporters of platinum-based anticancer agents and their clinical significance
Burger, H., Loos, W. J., Eechoute, K., Verweij, J., Mathijssen, R. H. J., & Wiemer, E. A. C. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.002 · Cited by 230
The pathological role of Bax in cisplatin nephrotoxicity
Wei, Q., Dong, G., Franklin, J., & Dong, Z. (2007) · Kidney International · doi:10.1038/sj.ki.5002256 · Cited by 228
Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms.
Heinecke, J. W., Kawamura, M., Suzuki, L., & Chait, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35347-5 · Cited by 214
Platinum-Induced Filamentous Growth in Escherichia coli
Rosenberg, B., Renshaw, E., Vancamp, L., Hartwick, J., & Drobnik, J. (1967) · Journal of Bacteriology · doi:10.1128/jb.93.2.716-721.1967 · Cited by 212
Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis
Jiang, M., Wei, Q., Wang, J., Du, Q., Yu, J., Zhang, L., & Dong, Z. (2006) · Oncogene · doi:10.1038/sj.onc.1209440 · Cited by 209
Apoptotic mechanisms in acute renal failure
Ueda, N., Kaushal, G. P., & Shah, S. V. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00311-9 · Cited by 201
Faubel, S., Ljubanovic, D., Reznikov, L., Somerset, H., Dinarello, C. A., & Edelstein, C. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66010.x · Cited by 196
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer
Cullen, K. J., Yang, Z., Schumaker, L., & Guo, Z. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9059-5 · Cited by 194
Servais, H., Ortiz, A., Devuyst, O., Denamur, S., Tulkens, P. M., & Mingeot-Leclercq, M.-P. (2008) · Apoptosis · doi:10.1007/s10495-007-0151-z · Cited by 193
Goffin, J., Lacchetti, C., Ellis, P. M., Ung, Y. C., & Evans, W. K. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c6f035 · Cited by 191
Apoptosis induced by cisplatin nephrotoxic injury
Lau, A. H. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00687.x · Cited by 187
Role of Reactive Oxygen Intermediates in Activation-induced CD95 (APO-1/Fas) Ligand Expression
Bauer, M. K. A., Vogt, M., Los, M., Siegel, J., Wesselborg, S., & Schulze-Osthoff, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8048 · Cited by 186
Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy
JACKSON, A. M., ROSE, B. D., GRAFF, L. G., JACOBS, J. B., SCHWARTZ, J. H., STRAUSS, G. M., YANG, J. P. S., RUDNICK, M. R., ELFENBEIN, I. B., & NARINS, R. G. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-41 · Cited by 184
Wu, Y. J., Muldoon, L. L., & Neuwelt, E. A. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075119 · Cited by 183
Endoplasmic Reticulum Stress–Associated Caspase 12 Mediates Cisplatin-Induced LLC-PK1 Cell Apoptosis
Liu, H., & Baliga, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090768 · Cited by 182
Cancer Chemotherapy and Antioxidants
Conklin, K. A. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.11.3201s · Cited by 181
Yonezawa, A., Masuda, S., Nishihara, K., Yano, I., Katsura, T., & Inui, K.-I. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.020 · Cited by 180
Nephrotoxicity of platinum complexes is related to basolateral organic cation transport
Ludwig, T., Riethmüller, C., Gekle, M., Schwerdt, G., & Oberleithner, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00720.x · Cited by 179
l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine
Chang, B., Nishikawa, M., Sato, E., Utsumi, K., & Inoue, M. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00342-9 · Cited by 175
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
Jiang, M., Yi, X., Hsu, S., Wang, C.-Y., & Dong, Z. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00262.2004 · Cited by 175
Seth, R., Yang, C., Kaushal, V., Shah, S. V., & Kaushal, G. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503305200 · Cited by 173
Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity
Sanchez-Gonzalez, P. D., Lopez-Hernandez, F. J., Perez-Barriocanal, F., Morales, A. I., & Lopez-Novoa, J. M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr195 · Cited by 173
Liu, H., & Baliga, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00908.x · Cited by 171
Satoh, M., Kashihara, N., Fujimoto, S., Horike, H., Tokura, T., Namikoshi, T., Sasaki, T., & Makino, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047522 · Cited by 168
Lynch, E. D., Gu, R., Pierce, C., & Kil, J. (2005) · Hearing Research · doi:10.1016/j.heares.2004.08.002 · Cited by 167
Park, M., Helip-Wooley, A., & Thoene, J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000036867.49866.59 · Cited by 167
Baek, S. M., Kwon, C. H., Kim, J. H., Woo, J. S., Jung, J. S., & Kim, Y. K. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00111-2 · Cited by 166
Santos, N. A. G., Bezerra, C. S. C., Martins, N. M., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0459-y · Cited by 165
Self-citationRegulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
Jiang, M., & Dong, Z. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139162 · Cited by 162
Pabla, N., Dong, G., Jiang, M., Huang, S., Kumar, M. V., Messing, R. O., & Dong, Z. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45586 · Cited by 153
Lee, R. H., Song, J. M., Park, M. Y., Kang, S. K., Kim, Y. K., & Jung, J. S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00748-1 · Cited by 150
Jiang, M., Wei, Q., Pabla, N., Dong, G., Wang, C., Yang, T., Smith, S. B., & Dong, Z. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.010 · Cited by 149
The Mechanism of Action of Cisplatin: From Adducts to Apoptosis
Eastman, A. R. (1999) · Wiley eBooks · doi:10.1002/9783906390420.ch4 · Cited by 145
Peyrou, M., Hanna, P. E., & Cribb, A. E. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm152 · Cited by 141
Casarett and Doull's toxicology
Klaassen, C. D., & Watkins, J. B. (2013) · Cited by 140
Ctr1 and its role in body copper homeostasis
Sharp, P. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00134-6 · Cited by 138
Townsend, D. M., & Hanigan, M. H. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.142 · Cited by 138
Resveratrol attenuates cisplatin-induced nephrotoxicity in rats
do Amaral, C. L., Francescato, H. D. C., Coimbra, T. M., Costa, R. S., Darin, J. D. C., Antunes, L. M. G., & Bianchi, M. D. L. P. (2007) · Archives of Toxicology · doi:10.1007/s00204-007-0262-x · Cited by 132
Ischemic kidney injury and mechanisms of tissue repair
El-Sabbahy, M., & Vaidya, V. S. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.133 · Cited by 121
Cumulative toxicities from cisplatin therapy and current cytoprotective measures
Cvitkovic, E. (1998) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(98)90061-5 · Cited by 119
Enoksson, M., Robertson, J. D., Gogvadze, V. G., Bu, P., Kropotov, A., Zhivotovsky, B., & Orrenius, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400374200 · Cited by 116
γ-Glutamyl Transpeptidase-Deficient Mice Are Resistant to the Nephrotoxic Effects of Cisplatin
Hanigan, M. H., Lykissa, E. D., Townsend, D. M., Ou, C., Barrios, R. J., & Lieberman, M. W. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63035-0 · Cited by 115
Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role
Helm, C. W., & States, J. C. (2009) · Journal of Ovarian Research · doi:10.1186/1757-2215-2-2 · Cited by 110
Radiosensitizers in cervical cancer. Cisplatin and beyond
Candelaria, M., Garcia-Arias, A., Cetina, L., & Dueñas‐González, A. (2006) · Radiation Oncology · doi:10.1186/1748-717x-1-15 · Cited by 110
Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity
Baliga, R., Zhang, Z., Baliga, M., Ueda, N., & Shah, S. V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00161.x · Cited by 110
Protecting Cisplatin-Induced Nephrotoxicity with Cimetidine Does Not Affect Antitumor Activity
Katsuda, H., Yamashita, M., Katsura, H., Yu, J., Waki, Y., Nagata, N., Sai, Y., & Miyamoto, K. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1867 · Cited by 108
Rosiglitazone ameliorates cisplatin-induced renal injury in mice
Lee, S., Kim, W. K., Moon, S.-O., Sung, M. J., Kim, D. H., Kang, K. P., Jang, Y. B., Lee, J. E., Jang, K. Y., & Park, S. K. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl194 · Cited by 108
Koyner, J. L., Ali, R. S., & Murray, P. T. (2008) · Nephron Experimental Nephrology · doi:10.1159/000142935 · Cited by 105
Endothelin B Receptor-Mediated Regulation of ATP-Driven Drug Secretion in Renal Proximal Tubule
Masereeuw, R., Terlouw, S. A., van Aubel, R. A., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26442-7 · Cited by 101
Yang, C., Kaushal, V., Haun, R. S., Seth, R., Shah, S. V., & Kaushal, G. P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402287 · Cited by 100
Katzenstein, H. M., Chang, K. W., Krailo, M., Chen, Z., Finegold, M. J., Rowland, J., Reynolds, M., Pappo, A. S., London, W. B., & Malogolowkin, M. H. (2009) · Cancer · doi:10.1002/cncr.24667 · Cited by 96
Mitochondrial alterations in cisplatin-induced acute renal failure
Gordon, J. A., & Gattone, V. H. (1986) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1986.250.6.f991 · Cited by 95
Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity
Mishima, K., Baba, A., Matsuo, M., Itoh, Y., & Oishi, R. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.025 · Cited by 90
Jia, Z., Wang, N., Aoyagi, T., Wang, H., Liu, H., & Yang, T. (2010) · Kidney International · doi:10.1038/ki.2010.331 · Cited by 88
Olivero, O. A., Chang, P. K., López‐Larraza, D. M., Semino-Mora, M. C., & Poirier, M. C. (1997) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s0165-1218(97)00037-2 · Cited by 83
Enhancement of the antiproliferative activity of cis‐diamminedichloroplatinum(II) by quercetin
Hofmann, J., Fiebig, H. H., Winterhalter, B. R., Berger, D. P., & Grunicke, H. H. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450327 · Cited by 82
Treskes, M., Nijtmans, L. G. J., Fichtinger-Schepman, A. M. J., & van der Vijgh, W. J. F. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90607-k · Cited by 80
Chemotherapy in advanced bladder cancer: current status and future
Ismaili, N., Amzerin, M., & Fléchon, A. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-35 · Cited by 77
Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells
Cilenti, L., Kyriazis, G. A., Soundarapandian, M. M., Stratico, V., Yerkes, A., Park, K. M., Sheridan, A. M., Alnemri, E. S., Bonventre, J. V., & Zervos, A. S. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00154.2004 · Cited by 74
Dong, G., Luo, J., Subbiah, V. K., & Dong, Z. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00410.2009 · Cited by 70
Functional TauT Protects Against Acute Kidney Injury
Han, X., Yue, J., & Chesney, R. W. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050465 · Cited by 61
Rodrigues, M. A. C., Rodrigues, J. L., Martins, N. M., Barbosa, F., Curti, C., dos Santos, N. A. G., & dos Santos, A. C. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.10.014 · Cited by 60
Self-citationTarladaçalişir, Y. T., Kanter, M., & Uygun, M. (2008) · Renal Failure · doi:10.1080/08860220701742070 · Cited by 59
Ajith, T. A., Abhishek, G., Roshny, D., & Sudheesh, N. P. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2008.12.002 · Cited by 58
Kachadourian, R., Leitner, H., & Day, B. J. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.1.161 · Cited by 58
Carvedilol protects against the renal mitochondrial toxicity induced by cisplatin in rats
Rodrigues, M. A. C., Rodrigues, J. L., Martins, N. M., et al. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.09.001 · Cited by 42
Self-citationBlanářová, O. V., Jelínková, I., Szöőr, Á., Skender, B., Souček, K., Horváth, V., Vaculová, A. H., Anděra, L., Sova, P., Szöllõsi, J., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq220 · Cited by 42
Liu, H., Baliga, M., & Baliga, R. (2002) · PubMed · Cited by 38
Block, K. I., & Gyllenhaal, C. (2005) · Integrative Cancer Therapies · doi:10.1177/1534735405282842 · Cited by 37
Campbell, M. T., Dagher, P. C., Hile, K. L., Zhang, H., Meldrum, D. R., Rink, R. C., & Meldrum, K. K. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.08.001 · Cited by 33
Antioxidant and prooxidant effects of quercetin on glyceraldehyde-3-phosphate dehydrogenase
Schmalhausen, E. V., Zhlobek, E. B., Shalova, I. N., Firuzi, O., Saso, L., & Muronetz, V. I. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.04.015 · Cited by 32
The Membrane Paradigm for Black Holes
Price, R. H., & Thorne, K. S. (1988) · Scientific American · doi:10.1038/scientificamerican0488-69 · Cited by 32
Stress response inhibits the nephrotoxicity of cisplatin
Hanigan, M. H., Deng, M., Zhang, L., et al. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00041.2003 · Cited by 31
Wu, X., & Kakehi, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2667 · Cited by 29
Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury
Li, M., Balamuthusamy, S., Khan, A. M., Maderdrut, J. L., Simon, E. E., & Batuman, V. (2009) · Peptides · doi:10.1016/j.peptides.2009.12.018 · Cited by 28
From finch to fish to man: Role of aquaporins in body fluid and brain water regulation
Schrier, R. W., Chen, Y.-C., & Cadnapaphornchai, M. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.043 · Cited by 28
Oxidative Stress in Cancer Biology and Therapy
Spitz, D., Dornfeld, K., Krishnan, K., & Gius, D. (2012) · Oxidative Stress in Applied Basic Research and Clinical Practice · doi:10.1007/978-1-61779-397-4 · Cited by 23
Toxic effects of dimethylthiourea in rats.
Beehler, C. J., Ely, M. E., RUTLEDGE, K. S., Simchuk, M. L., Reiss, O. K., Shanley, P. F., & Repine, J. E. (1994) · PubMed · Cited by 21
Coadministration of dimethyl sulfoxide reduces cisplatin nephrotoxicity.
Jones, M. M., Basinger, M. A., Field, L., & Holscher, M. A. (1991) · PubMed · Cited by 20
Rjiba-Touati, K., Ayed‐Boussema, I., Bouaziz, C., Belarbia, A., Azzabi, A., Achour, A., Hassen, W., & Bacha, H. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2011.589440 · Cited by 19
Enhancement of renal and hepatic glutathione metabolism by dimethylthiourea
Milner, L. S., Wei, S. H., & Houser, M. T. (1993) · Toxicology Letters · doi:10.1016/0378-4274(93)90086-d · Cited by 11
Antioxidants and Inhibition of Cisplatin-Induced Kidney Injury: Role of Mitochondria
dos Santos, N. A. G., & dos Santos, A. C. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-397-4_20 · Cited by 3
Cited by
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Surai, P. (2015) · Antioxidants · doi:10.3390/antiox4010204 · Cited by 738
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
van den Boogaard, W. M. C., Komninos, D. S. J., & Vermeij, W. P. (2022) · Cancers · doi:10.3390/cancers14030627 · Cited by 458
Advances in Toxicological Research of the Anticancer Drug Cisplatin
Qi, L., Luo, Q., Zhang, Y., Jia, F., Zhao, Y., & Wang, F. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00204 · Cited by 440
Volarevic, V., Djokovic, B., Jankovic, M. G., Harrell, C. R., Fellabaum, C., Djonov, V., & Arsenijevic, N. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0518-9 · Cited by 438
Natural products: potential treatments for cisplatin-induced nephrotoxicity
Fang, C.-Y., Lou, D.-Y., Zhou, L.-Q., Wang, J.-C., Yang, B., He, Q.-J., Wang, J.-J., & Weng, Q.-J. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00620-9 · Cited by 397
Metadata
- Authors
- dos Santos, N. A. G., Carvalho Rodrigues, M. A., Martins, N. M., & dos Santos, A. C.
- Venue
- Archives of Toxicology
- Published
- 2012-03-01
- Volume
- 86
- Issue
- 8
- Pages
- 1233-1250
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2063634819
- Cited by
- 378
- References
- 150
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.